Crossref journal-article
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences (341)
Abstract

Human telomerase, a cellular reverse transcriptase (hTERT), is a nuclear ribonucleoprotein enzyme complex that catalyzes the synthesis and extension of telomeric DNA. This enzyme is specifically activated in most malignant tumors but is usually inactive in normal somatic cells, suggesting that telomerase plays an important role in cellular immortalization and tumorigenesis. Terminal maturation of tumor cells has been associated with the repression of telomerase activity. Using maturation-sensitive and -resistant NB4 cell lines, we analyzed the pattern of telomerase expression during the therapeutic treatment of acute promyelocytic leukemia (APL) by retinoids. Two pathways leading to the down-regulation of hTERT and telomerase activity were identified. The first pathway results in a rapid down-regulation of telomerase that is associated with retinoic acid receptor (RAR)-dependent maturation of NB4 cells. Furthermore, during NB4 cell maturation, obtained independently of RAR by retinoic X receptor (RXR)-specific agonists (rexinoids), no change in telomerase activity was observed, suggesting that hTERT regulation requires a specific signaling and occurs autonomously. A second pathway of hTERT regulation, identified in the RAR-responsive, maturation-resistant NB4-R1 cell line, results in a down-regulation of telomerase that develops slowly during two weeks of all- trans retinoic acid (ATRA) treatment. This pathway leads to telomere shortening, growth arrest, and cell death, all events that are overcome by ectopic expression of hTERT. These findings demonstrate a clear and full dissociation between the process of tumor cell maturation and the regulation of hTERT mRNA expression and telomerase activity by retinoids. We propose telomerase expression as an efficient and selective target of retinoids in the therapy of tumors.

Bibliography

Pendino, F., Flexor, M., Delhommeau, F., Buet, D., Lanotte, M., & Ségal-Bendirdjian, E. (2001). Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proceedings of the National Academy of Sciences, 98(12), 6662–6667.

Authors 6
  1. Frédéric Pendino (first)
  2. Maria Flexor (additional)
  3. François Delhommeau (additional)
  4. Dorothée Buet (additional)
  5. Michel Lanotte (additional)
  6. Evelyne Ségal-Bendirdjian (additional)
References 49 Referenced 75
  1. 10.1146/annurev.bi.61.070192.000553
  2. 10.1016/S0092-8674(00)81123-X
  3. 10.1126/science.279.5349.334
  4. 10.1101/SQB.1994.059.01.035
  5. 10.1038/345458a0
  6. 10.1073/pnas.89.21.10114
  7. 10.1002/j.1460-2075.1992.tb05245.x
  8. 10.1126/science.7544491
  9. 10.1126/science.275.5302.973
  10. 10.1126/science.277.5328.955
  11. 10.1016/S0092-8674(00)80538-3
  12. 10.1093/hmg/6.12.2011
  13. 10.1038/ng1297-498
  14. 10.1016/S0960-9822(98)70067-3
  15. M Takakura, S Satoru, T Kanaya, H Hirano, J Takeda, M Yutsudo, M Inoue Cancer Res 59, 551–557 (1999). / Cancer Res by Takakura M (1999)
  16. O Horikawa, P L Cable, C Afshari, J C Barrett Cancer Res 59, 826–830 (1999). / Cancer Res by Horikawa O (1999)
  17. 10.1038/sj.onc.1202669
  18. C Gunes, S Lichtsteiner, A P Vasserot, C Englert Cancer Res 60, 2116–2121 (2000). / Cancer Res by Gunes C (2000)
  19. 10.1073/pnas.95.18.10471
  20. 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3
  21. G A Ulaner, J-F Hu, T H Vu, L C Giudice, A R Hoffman Cancer Res 58, 4168–4172 (1998). / Cancer Res by Ulaner G A (1998)
  22. 10.1006/excr.1998.4102
  23. S Kyo, M Takakura, T Kanaya, W Zhuo, K Fujimoto, Y Nishio, A Orimo, M Inoue Cancer Res 59, 5917–5921 (1999). / Cancer Res by Kyo S (1999)
  24. 10.1016/S0002-9440(10)65712-4
  25. 10.1038/sj.onc.1201553
  26. 10.1073/pnas.96.1.226
  27. 10.1128/MCB.20.11.3764-3771.2000
  28. 10.1210/endo.137.12.8940411
  29. 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O
  30. 10.1016/S0304-3835(98)00270-5
  31. 10.1073/pnas.92.26.12343
  32. L J Bestilny, C B Brown, Y Miura, L D Robertson, K T Riabowol Cancer Res 56, 3796–3802 (1996). / Cancer Res by Bestilny L J (1996)
  33. D Xu, A Gruber, C Peterson, P Pisa Leukemia 10, 1354–1357 (1996). / Leukemia by Xu D (1996)
  34. J Albanell, W Wan, B Mellado, R Guanawardane, H I Scher, E Dmitrovsky, M A S Moore Cancer Res 56, 1503–1508 (1996). / Cancer Res by Albanell J (1996)
  35. 10.1046/j.1432-0436.1997.6150321.x
  36. 10.1016/S0145-2126(98)00065-4
  37. 10.1038/sj.bjc.6690480
  38. 10.1182/blood.V77.5.1080.1080
  39. 10.1038/347558a0
  40. E Duprez, S Ruchaud, G Houge, V Martin-Thouvenin, F Valensi, P Kastner, R Berger, M Lanotte Leukemia 6, 1281–1287 (1992). / Leukemia by Duprez E (1992)
  41. 10.1073/pnas.91.18.8428
  42. 10.1093/emboj/18.24.7011
  43. 10.1038/sj.leu.2401683
  44. A Bruel, G Benoit, D De Nay, M Lanotte Leukemia 9, 1173–1184 (1995). / Leukemia by Bruel A (1995)
  45. 10.1126/science.7605428
  46. 10.1016/S1074-7613(00)80105-3
  47. 10.1038/22780
  48. 10.1073/pnas.95.1.90
  49. 10.1096/fasebj.10.9.8801176
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 10:44 a.m.)
Deposited 3 years, 4 months ago (April 12, 2022, 8:38 p.m.)
Indexed 1 year, 1 month ago (July 27, 2024, 11:58 a.m.)
Issued 24 years, 3 months ago (May 22, 2001)
Published 24 years, 3 months ago (May 22, 2001)
Published Online 24 years, 3 months ago (May 22, 2001)
Published Print 24 years, 3 months ago (June 5, 2001)
Funders 0

None

@article{Pendino_2001, title={Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation}, volume={98}, ISSN={1091-6490}, url={http://dx.doi.org/10.1073/pnas.111464998}, DOI={10.1073/pnas.111464998}, number={12}, journal={Proceedings of the National Academy of Sciences}, publisher={Proceedings of the National Academy of Sciences}, author={Pendino, Frédéric and Flexor, Maria and Delhommeau, François and Buet, Dorothée and Lanotte, Michel and Ségal-Bendirdjian, Evelyne}, year={2001}, month=may, pages={6662–6667} }